Based on our findings, we propose that inhibiting DLX6-AS1 activity could enhance miR-16 expression, which, in turn, can induce autophagy (as shown in Fig. 7) and apoptosis in cancer cells by inhibiting BMI1 and mTORs. Here, DLX6 is linked to cancer.